-+ 0.00%
-+ 0.00%
-+ 0.00%

Roth Capital Maintains Neutral on Core Scientific, Lowers Price Target to $17

Benzinga·08/22/2025 17:21:21
Listen to the news
Roth Capital analyst Darren Aftahi maintains Core Scientific (NASDAQ:CORZ) with a Neutral and lowers the price target from $20 to $17.